<
 
 
 
 
×
>
hide
You are viewing a Web site, archived on 01:30:36 Nov 08, 2004. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection. Note that this document was downloaded, and not saved because it was a duplicate of a previously captured version (00:25:33 Oct 29, 2004). HTTP headers presented here are from the original capture.
Skip page top navigationFDA Logo--links to FDA home page Logo of and Link to start page of Office of Regulatory Affairs, U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

 

Welcome to Compliance References
This page provides links, for example, to documents, lists, policies, programs, and statements relating to Compliance References used by FDA personnel:

Revisions

Revisions, Drafts, and Updates to ORA compliance references

 

Manuals

Other Compliance Documents

  • Application Integrity Policy
    Regarding the integrity of data and information in applications submitted for FDA review and approval.
  • Bioresearch Monitoring Program
    (BIMO) of on-site inspections and data audits designed to monitor all aspects of the conduct and reporting of FDA regulated research.  The BIMO Program was established to assure the quality and integrity of data submitted to the agency in support of  new product approvals, as well as, to provide for protection of the rights and welfare of the thousands of human subjects involved in FDA regulated research.
  • Disqualified/Restricted/Assurance List for Clinical Investigators
    Restricted from receiving investigational drugs, biologics, or devices if FDA determines that the investigator has repeatedly or deliberately failed to comply with regulatory requirements for studies or has submitted false information to the study's sponsor.
  • Electronic Records; Electronic Signatures, 21 CFR Part 11
    Background information and updates on the rule that allows the use of electronic records and electronic signatures for any  record that is required to be kept and maintained by other FDA regulations.
  • FDA Debarment List
    Firms or individuals convicted of a felony under Federal law for conduct (by a firm) relating to the development or approval, including the process for development or approval, of any abbreviated drug application; or (an individual convicted) for conduct relating to development or approval of any drug product, or otherwise relating to any drug product under the Federal Food, Drug, and Cosmetic Act.
  • Public Health Service (PHS) Administrative Actions Listings
    Of certain individuals who have had administrative actions imposed against them. The list is maintained by the PHS Office of Research Integrity (ORI).
  • Reading Room (Electronic Freedom of Information Act)
    ORA documents frequently requested by the public through the Freedom of Information Act.
  • Recalls of FDA Regulated Products
    Information regarding guidance to industry on product recalls, model press releases for product recalls, and links to FDA listings of recalls: the most recent and critical recalls, and weekly archives of all recalls from approximately 1990.

Page updated: August 2, 2004